RankAlpha logo
Back to Rankings

ZNTL

ZentalisC
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-20
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
ZNTL vs peer average
58/100
ZNTL vs. peer average (C vs. C)
Grade spread
A 1 · B 1 · C 2 · D 4 · F 2
Graded peers loaded
Coverage
10 graded
91% of tracked

Peer overview

IMRX is the first available peer comparator.

Loose small-cap biotech peer useful mainly for benchmarking how clinical-stage names trade around readouts, execution checkpoints, and runway rather than current revenue.

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerIMRXImmuneering
ZNTL
Zentalis
IMRX
Immuneering
Grade
C
B
Momentum
93
35
Value
41
41
Sentiment
29
87
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Constructive
Open Side-by-Side ComparisonCompare all

Grade position vs IMRX

ZNTL / IMRX
Grade Position
In line
ZNTL vs. peer average (C vs. C)
58/100
Momentum
93
ZNTL
Value
41
ZNTL
Sentiment
29
IMRX

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs ZNTL
1
IMRX
IMRX
B
80/100
-1
2
MGNX
MGNX
C
60/100
Even
3
ELDN
ELDN
F
20/100
+2
4
FENC
Fennec Pharmaceuticals Inc Common
C
60/100
Even
5
AKBA
Akebia Therapeutics Inc Common
D
40/100
+1
IMRX is the first peer returned for this comparison set.